Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025)

Nano-X Imaging (NNOX) posted quarterly Cash from Financing Activities of $15.5 million for Q4 2025, down 59.01% year-on-year from $37.8 million in Q4 2024, and up 170.35% on a QoQ basis from $5.7 million in Q3 2025.

Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025) Analysis & Trends

Nano-X Imaging (NNOX) has reported Cash from Financing Activities for 5 consecutive years, with $15.5 million the latest figure, recorded in Q4 2025.

  • Quarterly Cash from Financing Activities fell 59.01% year-over-year to $15.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.4 million (down 45.91% YoY) and the FY2025 annual result came in at $21.4 million, down 45.91% from the prior year.
  • Cash from Financing Activities improved to $15.5 million in Q4 2025 per NNOX's latest filing, from $5.7 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for NNOX reached as high as $37.8 million in Q4 2024 and fell as low as -$12.0 million in Q2 2021.
  • A 5-year average of $5.1 million and a median of $176000.0 in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2023 — Cash from Financing Activities sank 368.84% — and 2024, when it surged 114560.61%.
  • Year by year, Cash from Financing Activities stood at $1.0 million in 2021, then sank by 83.33% to $174000.0 in 2022, then slumped by 81.03% to $33000.0 in 2023, then jumped by 114560.61% to $37.8 million in 2024, then tumbled by 59.01% to $15.5 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $15.5 million, $5.7 million, and $121000.0 for Q4 2025, Q3 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Nano-X Imaging 67.53 Mn 23.68 Mn -2.59 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 15.51 Mn
Dec 31, 2025 15.51 Mn
Sep 30, 2025 5.74 Mn
Sep 30, 2025 5.74 Mn
Mar 31, 2025 121,000.00
Mar 31, 2025 121,000.00
Dec 31, 2024 37.84 Mn
Dec 31, 2024 37.84 Mn
Sep 30, 2024 1.62 Mn
Sep 30, 2024 1.62 Mn
Jun 30, 2024 21,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 24,000.00
Mar 31, 2024 24,000.00
Dec 31, 2023 33,000.00
Dec 31, 2023 33,000.00
Sep 30, 2023 27.41 Mn
Sep 30, 2023 27.41 Mn
Jun 30, 2023 -371,000.00
Jun 30, 2023 -371,000.00